In the present study, we sought to better understand the role of TLR4 activation in SSc, by investigating the clinical correlations between the expression of TLR4 and its co-receptors, MD2 and CD14, in the skin of SSc patients, and by investigating in vivo the effect of chronic cutaneous LPS exposure. The gene discussed is CD14; the disease is systemic sclerosis.